Kostas Stamatopoulos
Institute of Applied Biosciences
Centre for Research and Technology Hellas
Kostas Stamatopoulos has not added Biography.
If you are Kostas Stamatopoulos and would like to personalize this page please email our Author Liaison for assistance.
Immunogenetic studies of chronic lymphocytic leukemia: revelations and speculations about ontogeny and clinical evolution.
Cancer research Aug, 2014 | Pubmed ID: 25074616
Translocation t(2;7)(p11.2;q21.2): a rare genetic aberration associated with B-cell lymphoproliferative disorders of marginal-zone origin.
Cancer genetics Jun, 2014 | Pubmed ID: 25178943
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.
Blood Jan, 2015 | Pubmed ID: 25634617
Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8.
Blood Jun, 2015 | Pubmed ID: 25900981
Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation.
Haematologica Nov, 2015 | Pubmed ID: 26294727
An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2016 | Pubmed ID: 26647217
B Cell Anergy Modulated by TLR1/2 and the miR-17∼92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4.
Journal of immunology (Baltimore, Md. : 1950) 05, 2016 | Pubmed ID: 27059597
Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference.
Haematologica 07, 2016 | Pubmed ID: 27102498
Binding of CLL subset 4 B-cell receptor immunoglobulins to viable human memory B lymphocytes requires a distinctive IGKV somatic mutation.
Molecular medicine (Cambridge, Mass.) Mar, 2017 | Pubmed ID: 28097289
Clonal B-cell lymphocytosis of marginal zone origin.
Best practice & research. Clinical haematology Mar - Jun, 2017 | Pubmed ID: 28288720
Numerous Ontogenetic Roads to Mantle Cell Lymphoma: Immunogenetic and Immunohistochemical Evidence.
The American journal of pathology Jul, 2017 | Pubmed ID: 28457696
Monoclonal B-cell lymphocytosis in a hospital-based UK population and a rural Ugandan population: a cross-sectional study.
The Lancet. Haematology Jul, 2017 | Pubmed ID: 28668191
Calreticulin as a novel B-cell receptor antigen in chronic lymphocytic leukemia.
Haematologica 10, 2017 | Pubmed ID: 28751563
A gene is known by the company it keeps: enrichment of TNFAIP3 gene aberrations in MALT lymphomas expressing IGHV4-34 antigen receptors.
The Journal of pathology 12, 2017 | Pubmed ID: 28892161
Chronic Lymphocytic Leukemia Patient Clustering Based on Somatic Hypermutation (SHM) Analysis.
Advances in experimental medicine and biology , 2017 | Pubmed ID: 28971394
T cells in chronic lymphocytic leukemia: can they fight?
Oncotarget Nov, 2017 | Pubmed ID: 29245889
No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy.
Haematologica Apr, 2018 | Pubmed ID: 29269523
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia.
Haematologica Sep, 2018 | Pubmed ID: 30262567
Immunoglobulin Gene Analysis in Chronic Lymphocytic Leukemia.
Methods in molecular biology (Clifton, N.J.) , 2019 | Pubmed ID: 30350197
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.
International journal of cancer Nov, 2018 | Pubmed ID: 30447004
Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemia.
BMC bioinformatics Nov, 2018 | Pubmed ID: 30453883
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Andreas Agathangelidis*,1,
Lesley Ann Sutton*,2,3,
Anastasia Hadzidimitriou1,
Cristina Tresoldi4,
Anton W. Langerak5,
Chrysoula Belessi6,
Frederic Davi7,
Richard Rosenquist2,3,
Kostas Stamatopoulos1,2,
Paolo Ghia8
1Institute of Applied Biosciences, Centre for Research and Technology Hellas,
2Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University,
3Department of Molecular Medicine and Surgery, Karolinska Institutet,
4Division of Immunology, Transplantation and Infectious, IRCCS San Raffaele Scientific Institute,
5Department of Immunology, Laboratory for Medical Immunology, Erasmus University Medical Center,
6Hematology Department, Nikea General Hospital,
7, Assistance publique - Hôpitaux de Paris (AP-HP), Hopital Pitié-Salpêtrière, Department of Hematology, and UPMC University Paris 06, UMRS 1138,
8Division of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Università Vita-Salute San Raffaele
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados